Malignant neoplasm of adrenal gland
Chapter 2:Neoplasms
ICD-10 C74 is a billable code used to indicate a diagnosis of malignant neoplasm of adrenal gland.
Malignant neoplasms of the adrenal gland are tumors that arise from the adrenal cortex or medulla, which are responsible for producing hormones such as cortisol, aldosterone, and catecholamines. These tumors can disrupt normal hormone production, leading to various endocrine disorders. Common symptoms may include hypertension, weight gain, and abnormal glucose metabolism due to excess cortisol (Cushing's syndrome) or excess catecholamines (pheochromocytoma). Diagnosis typically involves imaging studies such as CT or MRI, along with biochemical tests to assess hormone levels. Treatment often requires surgical intervention, and in some cases, adjuvant therapy may be necessary. The prognosis varies based on tumor size, stage, and the presence of metastasis. Accurate coding is essential for proper reimbursement and tracking of treatment outcomes.
Detailed hormone level assessments, imaging results, and clinical notes on symptoms.
Patients presenting with symptoms of Cushing's syndrome or pheochromocytoma.
Ensure comprehensive documentation of hormonal assays and any endocrine dysfunction.
Pathology reports, staging information, and treatment plans.
Patients undergoing surgical resection of adrenal tumors or receiving chemotherapy.
Accurate staging and grading of tumors are crucial for coding and treatment planning.
Performed for resection of adrenal tumors.
Operative report detailing the procedure and findings.
Endocrinologists and oncologists should ensure accurate coding based on surgical findings.
Common symptoms include hypertension, weight gain, abnormal glucose metabolism, and signs of hormonal excess such as Cushing's syndrome or pheochromocytoma.
Diagnosis typically involves imaging studies like CT or MRI, along with biochemical tests to assess hormone levels and confirm malignancy through biopsy if necessary.
